The global sleep apnea diagnostics market was valued at $290.50 million in 2020, and is projected to reach $545.09 million by 2030, registering a CAGR of 6.7% from 2021 to 2030.
Sleep apnea is a sleeping disorder that can lead to serious health problems, including hypertension (high blood pressure), stroke, cardiomyopathy (enlargement of the muscle tissue of the heart), heart failure, diabetes and heart attacks. Untreated sleep apnea causes breathing to stop repeatedly during sleep, causing loud snoring and daytime tiredness, even with a full night’s sleep. Sleep apnea can affect anyone, but most often older men who are overweight. Sleep apnea occurs in about 25% of men and nearly 10% of women. It can affect people of all ages, including babies and children and particularly people over the age of 50 and those who are overweight. Certain physical traits and clinical features are common in patients with obstructive sleep apnea. These include excessive weight, large neck, and structural abnormalities reducing the diameter of the upper airway, such as nasal obstruction, a low-hanging soft palate, enlarged tonsils, or a small jaw with an overbite. Sleep apnea is caused by a blockage of the airway, usually when the soft tissue in the rear of the throat collapses during sleep. The diagnosis of this includes the sleep test like overnight sleep study called a polysomnogram (PSG) and a home sleep test (HST).
The growth of the global sleep apnea diagnostics market is driven by significant increase in the incidence of sedentary lifestyle disorders, including obesity, diabetes, and hypertension, working in shifts & stressful working environments cause sleep apnea, and various technological advancements in sleep apnea diagnostics devices. However, high cost of sleep apnea diagnostics and lack of awareness about the sleep apnea pose to restrain the growth of the sleep apnea diagnostics market. Conversely, untapped markets of developing economies are expected to offer lucrative opportunities during the forecast period.
Impact of COVID-19 Pandemic on Sleep Apnea Diagnostics Market (Pre and Post Analysis)
Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans. supply chains were disrupted due to restrictions on trade of pharmaceutical ingredients and products across countries. In addition, COVID 19 is an infectious disease with flu-like symptoms, including fever, cough, and difficulty in breathing. In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas of the sleep apnea diagnostics market. The banned trade with other nations and enforced travel restrictions, resulting in decline in diagnostics and surgical procedures in the first half of 2020. According to the study published in the British Journal of Surgery, around 28.4 million elective procedures were cancelled or postponed in May 2020, based on a 12-week period of peak disruption to hospital services due to COVID-19. There has been a significant reduction in hospitals and sleep laboratory-based diagnosis of sleep apnea.
The global sleep apnea diagnostics market is segmented into product, end user, and region. Depending on product, the market is fragmented into polysomnography (PSG) devices, actigraphy systems, respiratory polygraph, sleep apnea screening device, oximeter. On the basis of end user, it is bifurcated into hospital & sleep lab and homecare. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Product Segment Review
By product, the polysomnography device (PSG) segment was the major revenue contributor in 2020, and is expected to maintain this dominance throughout the forecast period. This is attributed to the wide use of PSG devices in hospitals & sleep labs, as PSG enables the doctor to monitor varied parameters of sleep apnea, such as brain activity, muscle activity, and breathing activity to get a comprehensive interpretation of what disorder the patient is suffering from.
By Product
Polysomnography Device segment is projected as one of the most lucrative segment.
End-user Segment Review
On the basis of end user, the market is divided into hospital & sleep lab and homecare. The hospital & sleep lab segment dominates the global sleep apnea diagnostics market, owing to the preference among patients to visit hospitals for the diagnosis of sleep apnea. In addition, sleep labs possess different equipment and medical settings required to monitor sleep apnea.
By End User
Hospitals & Sleep laboratories segment held a dominant position in 2020 and will continue to maintain the lead over the forecast period.
Region Segment Review
North America accounted for the highest market share in 2020, due to availability of advance therapeutics, higher spreading of awareness, and heavy expenditure by the government on healthcare, followed by Europe and Asia-Pacific. Pharmaceutical companies have focused on expanding their presence in emerging economies, which is anticipated to drive the market growth.
By Region
Asia-Pacific would exhibit the highest CAGR during 2020-2030.
Sleep Apnea Diagnostics Market Research Study Key Benefits:
- This report provides a detailed quantitative analysis of the current sleep apnea diagnostics market trends and forecast estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
- An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of factors that drive and restrain the growth of the global sleep apnea diagnostics market is provided.
- The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2030, in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help in understanding competitive outlook of the market.
Sleep Apnea Diagnostics Market Report Highlights
| Aspects | Details |
 By PRODUCT |
|
 By END USER |
|
 By Region |
|
 Key Market Players | NATUS MEDICAL INCORPORATED, NIHON KOHDEN CORPORATION, DEVILBISS HEALTHCARE, MEDTRONIC PLC, KONINKLIJKE PHILIPS N.V. (PHILIPS), RESMED INC, MINDRAY MEDICAL INTERNATIONAL LIMITED, CADWELL INDUSTRIES INC, SMITHS GROUP PLC. (SMITHS MEDICAL), SOMNOMEDICS GmbH |
Analyst Review
Obstructive sleep apnea (OSA) is a disorder caused by the repetitive collapse of the upper airway during sleep. It is the most common Trusted Source sleep-related breathing disorder. OSA occurs when the muscles supporting the soft tissues in your throat, such as your tongue and soft palate, relax. This causes your airway to narrow or even close, momentarily cutting off the breathing. Normally, air should flow smoothly from the mouth and nose into the lungs at all times, including during sleep. Periods when breathing stops completely are called apnea or apneic episodes. In OSA, the normal flow of air is repeatedly stopped throughout the night. OSA is most common among older males, but it can affect anyone, including children. The incidence rises following menopause, such that the rates are similar in men and postmenopausal women.
The factors such as increase in the incidence of sedentary lifestyle disorders, including obesity, diabetes, and hypertension, working in shifts and stressful working environments cause sleep apnea and various technological advancement in the sleep apnea diagnostics devices contribute to the growth of the market. However, the high cost of sleep apnea diagnostics and lack of awareness about the sleep apnea pose to restrain the growth of the sleep apnea diagnostics market. Conversely, untapped markets of developing economies are expected to offer lucrative opportunities during the forecast period.
The total market value of Sleep Apnea Diagnostics market is $545.09 million in 2030.
The forcast period for Sleep Apnea Diagnostics market is 2020 to 2030
The market value of Sleep Apnea Diagnostics market in 2020 is $291 million.
The base year is 2020 in Sleep Apnea Diagnostics market
Top companies such as ResMed Inc., Koninklijke Philips N.V., Nihon Kohden Corporation, SomnoMedics, and DeVilbiss Healthcare held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.
Polysomnography Device segment is the most influencing segment owing to significant increase in the incidence of sedentary lifestyle disorders, including obesity, diabetes, and hypertension.
New product launch, acquisition are the key trends in the Sleep Apnea Diagnostics market report
North America has the highest growth rate of 6.7% in the market which is growing due to to availability of advance therapeutics, higher spreading of awareness, and heavy expenditure by the government on healthcare.
Yes, the Sleep Apnea Diagnostics market companies are profiled in the report.
Yes, the Sleep Apnea Diagnostics market report provides PORTER Analysis
Loading Table Of Content...
